Cardiac Care 5-Year
Horizon Project Report
Bibliography
Executive
Summary
Background
Cardiac
Surgery
Other
States
Bibliography
Introduction
Cardiology
Issues and
Implications
Expert
Sources
Authors
Leape LL. Park RE. Bashore TM. Harrison JK. Davidson CJ. Brook RH. Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures.
American Heart Journal. 2000; 139 (1 Pt 1): 106-113
.
Squires S. Secrets of the heart.
Washington Post. 2000 Aug 8; Page Z12 Section: Health
..
New England Journal of Medicine. 1999; 341(26): 1949-1956
.
Katz S. Green SJ. Kaplan BM. Chepurko L. Goldner BG. Ong L. Nonrandomized comparison between stent deployment and percutaneous transluminal coronary angioplasty in acute myocardial infarction.
American Heart Journal. 2000; 139 (1 Pt 1): 44-51.
Goldschlager NF. Ryan T. Wenger NK. Acute MI: New therapies, new directions.
Patient Care. 1999; 33(8): 88-114
.
Stone GW. Brodie BR. Griffin JJ. Morice MC. Costantini C..
Journal of the American College of Cardiology. 1998; 31(1): 23-30
.
Faxon DP. Heger JW. Primary angioplasty - enduring the test of time.
New England Journal of Medicine. 1999; 341(19): 1464-1465..
New England Journal of Medicine. 1999; 341(19): 1413-1419.
Lauer MS. Primary angioplasty - time is of the essence.
JAMA. 2000; 283(22): 2988-2989.
Cucherat M. Bonnefoy E. Tremeau G. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction.
Cochrane Database of Systematic Reviews. (2): CD001560, 2000..
American Journal of Cardiology. 2000; 86(1): 41-45.
Bucher HC. Hengstler P. Schindler C. Guyatt GH. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomized controlled trials.
BMJ. 2000; 321(7253): 73-77.
Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SE, Pepine CJ, Watson RM. ACC/AHA Practice Guidelines for Coronary Angiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography).
Journal of the American College of Cardiology 1999; 33: 1756-1816.
Ryan TJ, Bauman WB, Kennedy JW, Kereiakes DJ, King III SB, McCallister BD, Smith Jr. SC, Ullyot DJ. Guidelines for Percutaneous Transluminal Coronary Angioplasty: ACC/AHA Task Force Report. Journal of the American College of Cardiology 1993; 22: 2033-2054.
American Heart Association. 2000 heart and stroke statistical update. Dallas, TX:
American Heart Association, 1999.
Pitt B. Waters D. Brown WV. van Boven AJ. Schwartz L. Title LM. Eisenberg D. Shurzinske L. McCormick LS. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.
New England Journal of Medicine. 1999; 341(2): 70-6.
Adele C. Vaitkus PT. Wells SK. Zehnacker JB. Cost advantages of an ad hoc angioplasty strategy.
Journal of the American College of Cardiology. 1998; 31(2): 321-325.-2947.-197
.
Jencks SF. Cuerdon T. Burwen DR. et al. Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels.
JAMA. 2000; 284(13): 1670-1676.
Dudley RA. Johansen KL. Brand R. et al. Selective referral to high-volume hospitals: estimating potentially avoidable deaths.
JAMA. 2000; 283: 1159-1166
.
Gregory PM. et al. New Jersey cardiac surgery capacity study: Access to cardiac surgery services.
Wenneker MB. Epstein AM. Racial inequalities in the use of procedures for patients with ischemic heart disease in Massachusetts.
JAMA. 1989; 261(2): 253-257.
Weintraub WS. We don't have the cure yet: ten-year follow-up after angioplasty.
Journal of Invasive Cardiology. 1999; 11(12): 729-731
.
Hannan. EL. Kilburn H Jr. Bernard H. et al. Coronary artery bypass surgery.
Medical Care. 1991; 29: 1094-1107
.
Hannan EL. Racz M. Ryan TJ. et al. Coronary angioplasty volume-outcome relationships for hospitals and cardiologists.
JAMA. 1997; 277(11): 892-898
.
Rosamond WD. Chambless LE. Folsom AR. Survival trends, coronary event rates, and the MONICA project.
The Lancet. 1999; 354(9181): 864-865
.
Pohost GM. Biederman RW. Doyle M. Cardiovascular magnetic resonance imaging and spectroscopy in the new millennium.
Curr Probl Cardiol. 2000; 25(8): 525-620
.
Winslow R. Hensley S. FDA is ready to approve new heart therapy.
Wall Street Journal. 2000 Nov. 3
.
Report Cover